0001214659-22-004371.txt : 20220325
0001214659-22-004371.hdr.sgml : 20220325
20220325174956
ACCESSION NUMBER: 0001214659-22-004371
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220323
FILED AS OF DATE: 20220325
DATE AS OF CHANGE: 20220325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHMIDT ERIC THOMAS
CENTRAL INDEX KEY: 0001754403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 22772692
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-55856.xml
PRIMARY DOCUMENT
X0306
4
2022-03-23
0001737287
Allogene Therapeutics, Inc.
ALLO
0001754403
SCHMIDT ERIC THOMAS
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Financial Officer
Common Stock
2022-03-23
4
A
false
237358
0
A
337904
D
Common Stock
1152595
I
See footnote
Stock Option (Right to Buy)
9.69
2022-03-23
4
A
false
368589
0.00
A
2032-03-23
Common Stock
368589
368589
D
25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter
The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
/s/ Veer Bhavnagri, Attorney-in-Fact for Eric Schmidt
2022-03-25